¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
¼¼°èÀÇ Ã´¼ö Àü±â ÀÚ±Ø ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 6¾ï 1,000¸¸ ´Þ·¯ ÀÌ»ó¿¡ ´ÞÇß½À´Ï´Ù. ÀÌ ½ÃÀåÀº 4.4%ÀÇ CAGR·Î È®´ëÇϸç, 2031³â¿¡´Â 8¾ï 2,000¸¸ ´Þ·¯ ÀÌ»ó¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
ÀÌ º¸°í¼´Â ´ÙÀ½ÀÇ µÎ °¡Áö ÇØºÎÇÐÀû ºÎ¹®À» ´ë»óÀ¸·Î ÇÕ´Ï´Ù. :
- °æºÎ Àü±â Àڱرâ
- ¿äÃß Àü±â Àڱرâ
Æ÷ÇÔµÈ ½ÃÀå µ¥ÀÌÅÍ
- ÆÇ¸Å·®
- Æò±ÕÆÇ¸Å°¡°Ý(ASP)
- ½ÃÀå ±Ô¸ð ¹× ¼ºÀå µ¿Çâ
- ¼ö¼ú °Ç¼ö
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ
- 2031³â±îÁö ½ÃÀå ¿¹Ãø
- 2024³â±îÁöÀÇ °ú°Å µ¥ÀÌÅÍ
- ÇÕº´ ¹× ÀμöÇÕº´
- ±â¾÷ °³¿ä ¹× Á¦Ç° Æ÷Æ®Æú¸®¿À
- ÁÖ¿ä °æÀï»ç ÀλçÀÌÆ®
¼¼°è ô¼ö Àü±âÀÚ±Ø ½ÃÀå µ¿Çâ
- ÃÖ¼Òħ½ÀÀû ôÃß °íÁ¤¼úÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿Ü·¡¿¡¼ Àü±â ÀڱرâÀÇ »ç¿ëÀÌ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù.
- ¹«¼± Á¦¾î ½Ã½ºÅÛ, ȯÀÚº° ÇÁ·Î±×·¡¹Ö ±â´ÉÀ» Æ÷ÇÔÇÑ Â÷¼¼´ë ÀÚ±Ø ±â¼ú °³¹ß ¹× °ü½É ±ÞÁõ.
- ÀÌ·¯ÇÑ ¹ßÀüÀº ôÃß °íÁ¤¼ú ÈÄ È¸º¹ ÁßÀΠȯÀÚÀÇ ¼øÀÀµµ, À¯È¿¼º, ÆíÀǼºÀ» Çâ»ó½ÃŰ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù.
¼¼°è ô¼ö Àü±â Àڱر⠽ÃÀå Á¡À¯À²¿¡ ´ëÇÑ ÀλçÀÌÆ®
- Orthofix
- 2024³â¿¡µµ ¼¼°è 1À§ ÀÚ¸®¸¦ À¯ÁöÇϸç Àüü ½ÃÀå Á¡À¯À² 50% ÀÌ»ó È®º¸.
- ƯÈ÷ ºÏ¹Ì¿Í ¼À¯·´¿¡¼ °æÃß¿Í ¿äÃß ºÎ¹®¿¡¼ ¾ÐµµÀûÀÎ ÁöÀ§¸¦ È®º¸.
- ºê·£µå ½Å·Úµµ, ±¤¹üÀ§ÇÑ ÀÓ»ó Áö¿ø, ¼¼°è º¸±ÞÀÌ °Á¡ÀÔ´Ï´Ù.
- ZimVie(Highridge Medical)
- ¼¼°è 2À§, ½ÃÀå Á¡À¯À² 5ºÐÀÇ 1 ÀÌ»ó.
- ¼À¯·´ ¹× ±âŸ Áö¿ªÀÇ ½ÅÈï ½ÃÀå¿¡¼ °·ÂÇÑ Á¸Àç°¨À» µå·¯³»°í ÀÖ½À´Ï´Ù.
- ôÃß °íÁ¤ Àڱؿ¡ Æ¯ÈµÈ Æ÷Æ®Æú¸®¿À°¡ ½ÃÀå È®´ë¿¡ ±â¿©.
- Enovis
- 2024³â, ¼¼°è ô¼ö Àü±âÀڱر⠽ÃÀå Á¡À¯À² 3À§ ´Þ¼º.
- ºÏ¹Ì¿¡¼ÀÇ È£½ÇÀû°ú ¼¼°è ½ÃÀå¿¡¼ÀÇ ÀÔÁö¸¦ À¯ÁöÇϰí ÀÖ½À´Ï´Ù.
- Áö¼ÓÀûÀÎ ¿¬±¸°³¹ß ÅõÀÚ¿Í ´Ù¾çÇÑ Á¤Çü¿Ü°ú Á¦Ç° Æ÷Æ®Æú¸®¿À°¡ °æÀï ¿ìÀ§¸¦ Áö¿øÇÕ´Ï´Ù.
½ÃÀå ¼¼ºÐÈ ¿ä¾à
- ÇØºÎÇк°
- °æºÎ Àü±â Àڱرâ
- ¿äÃß Àü±â Àڱرâ
¼¼°è Á¶»ç ¹üÀ§
- ´ë»ó Áö¿ª
- ºÏ¹Ì : ij³ª´Ù, ¹Ì±¹
- ¶óƾ¾Æ¸Þ¸®Ä« : ¾Æ¸£ÇîÆ¼³ª, º¼¸®ºñ¾Æ, ºê¶óÁú, Ä¥·¹, ÄÝ·Òºñ¾Æ, ÄÚ½ºÅ¸¸®Ä«, µµ¹Ì´ÏÄ« °øÈ±¹, ¿¡Äâµµ¸£, °úÅ׸»¶ó, ¸ß½ÃÄÚ, ÆÄ³ª¸¶, ÆÄ¶ó°úÀÌ, ÆÄ¶ó°úÀÌ, Æä·ç, Ǫ¿¡¸£Å丮ÄÚ, ¿ì·ç°úÀÌ, º£³×¼ö¿¤¶ó
- ¼À¯·´ ¿À½ºÆ®¸®¾Æ, º£³×·è½º, ÇÁ¶û½º, ÇÁ¶û½º, µ¶ÀÏ, ÀÌÅ»¸®¾Æ, Æ÷¸£Åõ°¥, Æ÷¸£Åõ°¥, ½ºÄµð³ªºñ¾Æ, ½ºÆäÀÎ, ½ºÀ§½º, ¿µ±¹
- Áßµ¿ºÎ À¯·´ : ¾ÆÁ¦¸£¹ÙÀÌÀÜ, ¹ßÆ® 3±¹, º§¶ó·ç½º, ºÒ°¡¸®¾Æ, ºÒ°¡¸®¾Æ, Å©·Î¾ÆÆ¼¾Æ, üÄÚ, Á¶Áö¾Æ, ±×¸®½º, Çë°¡¸®, Ä«ÀÚÈ彺ź, Æú¶õµå, ·ç¸¶´Ï¾Æ, ·¯½Ã¾Æ, ¼¼¸£ºñ¾Æ, ½½·Î¹ÙŰ¾Æ, ½½·Îº£´Ï¾Æ, ½½·Îº£´Ï¾Æ, Æ¢¸£Å°¿¹, ¿ìÅ©¶óÀ̳ª
- Áßµ¿ : ¹Ù·¹ÀÎ, À̶õ, À̽º¶ó¿¤, Äí¿þÀÌÆ®, ¿À¸¸, ¿À¸¸, īŸ¸£, »ç¿ìµð¾Æ¶óºñ¾Æ, ¾Æ¶ø¿¡¹Ì·¹ÀÌÆ®
- ¾Æ½Ã¾ÆÅÂÆò¾ç : È£ÁÖ, įº¸µð¾Æ, Áß±¹, È«Äá, Àεµ, Àεµ, Àεµ³×½Ã¾Æ, ÀϺ», ۸£±â½º½ºÅº, ¸¶Ä«¿À, ¸»·¹À̽þÆ, ¸ù°ñ, ¹Ì¾á¸¶, ¹Ì¾á¸¶, ´ºÁú·£µå, ÆÄŰ½ºÅº, Çʸ®ÇÉ, ½Ì°¡Æ÷¸£, Çѱ¹, ½º¸®¶ûÄ«, ´ë¸¸, ű¹, ¿ìÁŰ½ºÅº, º£Æ®³²
- ¾ÆÇÁ¸®Ä« : ¾ËÁ¦¸®, ÀÌÁýÆ®, ¿¡Æ¼¿ÀÇǾÆ, °¡³ª, ÄɳÄ, ÄɳÄ, ¸®ºñ¾Æ, ¸ð·ÎÄÚ, ³ªÀÌÁö¸®¾Æ, ³²¾ÆÇÁ¸®Ä«°øÈ±¹, ¼ö´Ü, ¿ì°£´Ù
- ±âÁØ ¿¬µµ: 2024³â
- ¿¹Ãø ±â°£: 2025-2031³â
- °ú°Å µ¥ÀÌÅÍ: 2021-2023³â
Á¤·®Àû µ¥ÀÌÅÍ
- ¼ö¼ú °Ç¼ö
- ½ÃÀå ±Ô¸ð
- ±â¾÷º°/ºÎ¹®º° ½ÃÀå Á¡À¯À²
- ½ÃÀå ¼ºÀå·ü ¿¹Ãø
- ÆÇ¸Å·®
- Æò±Õ ÆÇ¸Å °¡°Ý
Á¤¼ºÀû µ¥ÀÌÅÍ
- »õ·Î¿î ½ÃÀå µ¿Çâ
- ¼ºÀå ¾ïÁ¦¿äÀÎ
- °æÀï ±¸µµ
- ÇÕº´ ¹× ÀμöÇÕº´
- Á¦Ç° Æ÷Æ®Æú¸®¿À
- FDA ¸®ÄÝ ¹× ¾ÈÀü»ç°í
- ÆÄ±«Àû ±â¼ú
µ¥ÀÌÅÍ ¼Ò½º
- ¾÷°è ¸®´õ¿ÍÀÇ 1Â÷ ÀÎÅͺä
- Á¤ºÎ ¹× ±ÔÁ¦±â°ü µ¥ÀÌÅÍ
- º´¿ø Á¶´Þ µ¥ÀÌÅÍ
- ¼öÃâÀÔ ·Î±×
- »ç³» µ¥ÀÌÅͺ£À̽º
¼¼°èÀÇ Ã´¼ö Àü±â ÀÚ±Ø ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀåÀÇ °³¿ä¿Í ½ÃÀå ºÐ¼®°ú ¿¹Ãø, ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ, °æÀï ±¸µµ µîÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù.
¸ñÂ÷
ô¼ö Àü±â ÀÚ±Ø ½ÃÀå
°³¿ä
- ¼¼°èÀÇ Ã´¼ö Àü±â ÀÚ±Ø ½ÃÀå °³¿ä
- °æÀï ºÐ¼®
- ½ÃÀå ¼¼ºÐÈ
- ´ë»ó Áö¿ª
¼·Ð
½Ã¼ú °Ç¼ö
- ÀüÀü±â ÀÚ±ØÄ¡·á
- °æºÎ Àü±â ÀÚ±ØÄ¡·á
- ¿äÃß Àü±â ÀÚ±ØÄ¡·á
½ÃÀå °³¿ä
½ÃÀå ºÐ¼®°ú ¿¹Ãø
- Àü±â ÀÚ±Ø ½ÃÀå Àüü
- °æºÎ Àü±â ÀÚ±Ø ±â±â ½ÃÀå
- ¿äºÎ Àü±â ÀÚ±Ø ±â±â ½ÃÀå
ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ
°æÀï ½ÃÀå Á¡À¯À² ºÐ¼®
KSA 25.05.22
The global electrical stimulation market for spinal fusion was valued at over $610 million in 2024.
The market is projected to grow at a CAGR of 4.4%, reaching over $820 million by 2031.
The market report covers the following two anatomical segments:
- Cervical Electrical Stimulation Devices
- Lumbar Electrical Stimulation Devices
Market Data Included
- Unit Sales
- Average Selling Prices (ASPs)
- Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts to 2031
- Historical Data to 2024
- Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitor Insights
Global Spinal Electrical Stimulation Market Trends
- Growing adoption of minimally invasive spinal fusion procedures is driving the use of electrical stimulators in outpatient settings.
- Surge in development and interest around next-generation stimulation technologies, including:
- Wireless control systems
- Patient-specific programming features
- These advances aim to improve compliance, efficacy, and convenience for patients recovering from spinal fusion surgeries.
Global Spinal Electrical Stimulation Market Share Insights
- 1 Orthofix
- Maintained the leading global position in 2024, capturing over 50% of the total market share.
- Held dominant positions in both cervical and lumbar segments, particularly in North America and Western Europe.
- Strength attributed to brand trust, extensive clinical support, and broad global adoption.
- 2 ZimVie (Highridge Medical)
- Ranked second globally, with over one-fifth of total market share.
- Strong presence in Western Europe and emerging markets within the Rest of the World.
- Focused portfolio tailored for spinal fusion stimulation contributed to market expansion.
- 3 Enovis
- Held the third-largest share in the global spinal electrical stimulation market in 2024.
- Strong performance in North America and maintained presence globally.
- Continued R&D investment and a diversified orthopedic product portfolio supported its competitive positioning.
Market Segmentation Summary
- By Anatomy:
- Cervical Electrical Stimulation Devices
- Lumbar Electrical Stimulation Devices
Global Research Scope
- Regions Covered
- North America: Canada, United States
- Latin America: Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
- Western Europe: Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom
- Central & Eastern Europe: Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine
- Middle East: Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates
- Asia-Pacific: Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam
- Africa: Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda
- Base Year: 2024
- Forecast Period: 2025-2031
- Historical Data: 2021-2023
Quantitative Data
- Procedure Volumes
- Market Size
- Market Share by Company and Segment
- Forecasted Market Growth Rates
- Unit Sales
- Average Selling Prices
Qualitative Data
- Emerging Market Trends
- Limiting Factors
- Competitive Landscape
- Mergers & Acquisitions
- Product Portfolios
- FDA Recalls and Safety Events
- Disruptive Technologies
Data Sources
- Primary Interviews with Industry Leaders
- Government and Regulatory Agency Data
- Hospital Procurement Data
- Import & Export Logs
- iData Research Internal Databases
TABLE OF CONTENT
Electrical Stimulation Market
- 10.1 Executive Summary
- 10.1.1 Global Electrical Stimulation Market Overview
- 10.1.2 Competitive Analysis
- 10.1.3 Procedure Segmentation
- 10.1.4 Market Segmentation
- 10.1.5 Regions Included
- 10.2 Introduction
- 10.3 Procedure Numbers
- 10.3.1 Total Electrical Stimulation Procedures
- 10.3.2 Cervical Electrical Stimulation Procedures
- 10.3.3 Lumbar Electrical Stimulation Procedures
- 10.4 Market Overview
- 10.4.1 By Segment
- 10.4.2 By Region
- 10.5 Market Analysis and Forecast
- 10.5.1 Total Electrical Stimulation Market
- 10.5.2 Cervical Electrical Stimulation Device Market
- 10.5.3 Lumbar Electrical Stimulation Device Market
- 10.6 Drivers and Limiters
- 10.6.1 Market Drivers
- 10.6.2 Market Limiters
- 10.7 Competitive Market Share Analysis